Maxcyte (MXCT) EPS (Weighted Average and Diluted) (2020 - 2026)
Maxcyte (MXCT) reported EPS (Weighted Average and Diluted) of -$0.04 for Q1 2026, up 60.0% year-over-year from -$0.02 in Q1 2025, and up 55.56% quarter-over-quarter from -$0.09 in Q4 2025.
Maxcyte (MXCT) EPS (Weighted Average and Diluted) (2020 - 2026) Analysis & Trends
Maxcyte (MXCT) has 7 years of EPS (Weighted Average and Diluted) data on file, last reported at -$0.04 in Q1 2026.
- EPS (Weighted Average and Diluted) for Q1 2026 came in at -$0.04, up 60.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$0.37 (up 7.5% YoY), and the FY2025 annual result was -$0.42, down 7.69% from the prior year.
- EPS (Weighted Average and Diluted) improved to -$0.04 in Q1 2026 per MXCT's latest filing, from -$0.09 in the prior quarter.
- Over five years, EPS (Weighted Average and Diluted) peaked at -$0.04 in Q1 2022 and troughed at -$0.12 in Q2 2025.
- A 5-year average of -$0.09 and a median of -$0.09 in 2024 frame the typical range for EPS (Weighted Average and Diluted).
- The sharpest annual moves came in 2023 and 2026: EPS (Weighted Average and Diluted) tumbled 175.0% in 2023, then jumped 60.0% in 2026.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.05 in 2022, then climbed by 0.0% to -$0.05 in 2023, then slumped by 100.0% to -$0.1 in 2024, then climbed by 10.0% to -$0.09 in 2025, then jumped by 55.56% to -$0.04 in 2026.
- Business Quant data shows MXCT's EPS (Weighted Average and Diluted) at -$0.04 in Q1 2026, -$0.09 in Q4 2025, and -$0.12 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 0.61 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 1.93 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 0.89 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 0.66 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 0.51 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 0.85 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 2.24 |
| 10 | Maxcyte | 127.72 Mn | 127.72 Mn | 8.08 Mn | -0.04 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.04 |
| Dec 31, 2025 | -0.09 |
| Sep 30, 2025 | -0.12 |
| Jun 30, 2025 | -0.12 |
| Mar 31, 2025 | -0.10 |
| Dec 31, 2024 | -0.10 |
| Sep 30, 2024 | -0.11 |
| Jun 30, 2024 | -0.09 |
| Mar 31, 2024 | -0.09 |
| Dec 31, 2023 | -0.05 |
| Sep 30, 2023 | -0.11 |
| Jun 30, 2023 | -0.10 |
| Mar 31, 2023 | -0.11 |
| Dec 31, 2022 | -0.05 |
| Sep 30, 2022 | -0.06 |
| Jun 30, 2022 | -0.08 |
| Mar 31, 2022 | -0.04 |
| Dec 31, 2021 | -0.05 |
| Sep 30, 2021 | -0.03 |
| Jun 30, 2021 | -0.05 |